Literature DB >> 31860069

Improved brain perfusion after electrical cardioversion of atrial fibrillation.

Marianna Gardarsdottir1, Sigurdur Sigurdsson2, Thor Aspelund2,3, Valdis Anna Gardarsdottir4, Lars Forsberg2, Vilmundur Gudnason2,3, David O Arnar3,4.   

Abstract

AIMS: Atrial fibrillation (AF) has been associated with reduced brain volume, cognitive impairment, and reduced cerebral blood flow. The causes of reduced cerebral blood flow in AF are unknown, but no reduction was seen in individuals without the arrhythmia in a previous study. The aim of this study was to test the hypothesis that brain perfusion, measured with magnetic resonance imaging (MRI), improves after cardioversion of AF to sinus rhythm (SR). METHODS AND
RESULTS: All patients undergoing elective cardioversion at our institution were invited to participate. A total of 44 individuals were included. Magnetic resonance imaging studies were done before and after cardioversion with both brain perfusion and cerebral blood flow measurements. However, 17 did not complete the second MRI as they had a recurrence of AF during the observation period (recurrent AF group), leaving 17 in the SR group and 10 in the AF group to complete both measurements. Brain perfusion increased after cardioversion to SR by 4.9 mL/100 g/min in the whole brain (P < 0.001) and by 5.6 mL/100 g/min in grey matter (P < 0.001). Cerebral blood flow increased by 58.6 mL/min (P < 0.05). Both brain perfusion and cerebral blood flow remained unchanged when cardioversion was unsuccessful.
CONCLUSION: In this study of individuals undergoing elective cardioversion for AF, restoration, and maintenance of SR for at least 10 weeks after was associated with an improvement of brain perfusion and cerebral blood flow measured by both arterial spin labelling and phase contrast MRI. In those individuals where cardioversion was unsuccessful, there was no change in perfusion or blood flow. Published on behalf of the European Society of Cardiology. All rights reserved.
© The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  Atrial fibrillation; Brain perfusion; Brain volume; Cardioversion; Cerebral blood flow; Cognitive impairment

Year:  2020        PMID: 31860069      PMCID: PMC7132536          DOI: 10.1093/europace/euz336

Source DB:  PubMed          Journal:  Europace        ISSN: 1099-5129            Impact factor:   5.214


  22 in total

Review 1.  Cerebral microinfarcts: the invisible lesions.

Authors:  Eric E Smith; Julie A Schneider; Joanna M Wardlaw; Steven M Greenberg
Journal:  Lancet Neurol       Date:  2012-03       Impact factor: 44.182

2.  Quantitative cerebral blood flow in dynamic susceptibility contrast MRI using total cerebral flow from phase contrast magnetic resonance angiography.

Authors:  David Bonekamp; Mahaveer Degaonkar; Peter B Barker
Journal:  Magn Reson Med       Date:  2011-02-01       Impact factor: 4.668

3.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Europace       Date:  2016-08-27       Impact factor: 5.214

4.  Cerebral blood flow before and after cardioversion of atrial fibrillation.

Authors:  P Petersen; J Kastrup; R Videbaek; G Boysen
Journal:  J Cereb Blood Flow Metab       Date:  1989-06       Impact factor: 6.200

5.  Brain tissue volumes in the general population of the elderly: the AGES-Reykjavik study.

Authors:  Lenore J Launer; Vilmundur Gudnason; Sigurdur Sigurdsson; Thor Aspelund; Lars Forsberg; Jesper Fredriksson; Olafur Kjartansson; Bryndis Oskarsdottir; Palmi V Jonsson; Gudny Eiriksdottir; Tamara B Harris; Alex Zijdenbos; Mark A van Buchem
Journal:  Neuroimage       Date:  2011-11-13       Impact factor: 6.556

Review 6.  Atrial Fibrillation and Cognitive Decline: Phenomenon or Epiphenomenon?

Authors:  Shadi Kalantarian; Jeremy N Ruskin
Journal:  Cardiol Clin       Date:  2016-05       Impact factor: 2.213

7.  Ablation and pacing: improving brain perfusion and cognitive function in patients with atrial fibrillation and uncontrolled ventricular rates.

Authors:  Irina Efimova; Nataliya Efimova; Vladimir Chernov; Sergey Popov; Yuri Lishmanov
Journal:  Pacing Clin Electrophysiol       Date:  2011-11-29       Impact factor: 1.976

8.  Cerebral Perfusion and the Risk of Dementia: A Population-Based Study.

Authors:  Frank J Wolters; Hazel I Zonneveld; Albert Hofman; Aad van der Lugt; Peter J Koudstaal; Meike W Vernooij; M Arfan Ikram
Journal:  Circulation       Date:  2017-06-06       Impact factor: 29.690

9.  Atrial fibrillation is associated with reduced brain volume and cognitive function independent of cerebral infarcts.

Authors:  Hrafnhildur Stefansdottir; David O Arnar; Thor Aspelund; Sigurdur Sigurdsson; Maria K Jonsdottir; Haukur Hjaltason; Lenore J Launer; Vilmundur Gudnason
Journal:  Stroke       Date:  2013-02-26       Impact factor: 7.914

10.  Apixaban in patients at risk of stroke undergoing atrial fibrillation ablation.

Authors:  Paulus Kirchhof; Karl Georg Haeusler; Benjamin Blank; Joseph De Bono; David Callans; Arif Elvan; Thomas Fetsch; Isabelle C Van Gelder; Philip Gentlesk; Massimo Grimaldi; Jim Hansen; Gerhard Hindricks; Hussein R Al-Khalidi; Tyler Massaro; Lluis Mont; Jens Cosedis Nielsen; Georg Nölker; Jonathan P Piccini; Tom De Potter; Daniel Scherr; Ulrich Schotten; Sakis Themistoclakis; Derick Todd; Johan Vijgen; Luigi Di Biase
Journal:  Eur Heart J       Date:  2018-08-21       Impact factor: 29.983

View more
  6 in total

Review 1.  Impact of Catheter Ablation on Stroke, Cognitive Decline and Dementia.

Authors:  Tyson S Burnham; Monte L Scott; Benjamin A Steinberg; Daniel L Varela; Brian Zenger; T Jared Bunch
Journal:  Arrhythm Electrophysiol Rev       Date:  2021-10

2.  Commentary: Differential Risk of Dementia Between Patients With Atrial Flutter and Atrial Fibrillation: A National Cohort Study.

Authors:  Andrea Saglietto; Gaetano Maria De Ferrari; Matteo Anselmino
Journal:  Front Cardiovasc Med       Date:  2022-02-17

3.  Rhythm Control Better Prevents Dementia than Rate Control Strategies in Patients with Atrial Fibrillation-A Nationwide Cohort Study.

Authors:  Jiunn-Cherng Lin; Cheng-Hung Li; Yun-Yu Chen; Chi-Jen Weng; Yu-Shan Chien; Shang-Ju Wu; Chu-Pin Lo; Hui-Chun Tien; Ching-Heng Lin; Jin-Long Huang; Yenn-Jiang Lin; Yu-Cheng Hsieh; Shih-Ann Chen
Journal:  J Pers Med       Date:  2022-04-03

Review 4.  Insights from computational modeling on the potential hemodynamic effects of sinus rhythm versus atrial fibrillation.

Authors:  Matteo Anselmino; Stefania Scarsoglio; Luca Ridolfi; Gaetano Maria De Ferrari; Andrea Saglietto
Journal:  Front Cardiovasc Med       Date:  2022-09-14

5.  Atrial Fibrillation is Associated with Femoropopliteal Totally Occlusive In-Stent Restenosis: A Single-Center, Retrospective, Observational Study.

Authors:  Yohsuke Honda; Keisuke Hirano; Masahiro Yamawaki; Motoharu Araki; Norihiro Kobayashi; Yasunari Sakamoto; Shinsuke Mori; Masakazu Tsutsumi; Kenji Makino; Shigemitsu Shirai; Masafumi Mizusawa; Takahiro Nakano; Yoshiaki Ito
Journal:  J Interv Cardiol       Date:  2021-02-03       Impact factor: 2.279

Review 6.  Atrial fibrillation: a geriatric perspective on the 2020 ESC guidelines.

Authors:  M Cristina Polidori; Mariana Alves; Gulistan Bahat; Anne Sophie Boureau; Serdar Ozkok; Roman Pfister; Alberto Pilotto; Nicola Veronese; Mario Bo
Journal:  Eur Geriatr Med       Date:  2021-11-02       Impact factor: 1.710

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.